08:00 , Jan 19, 2004 |  BioCentury  |  Finance

Ebb & Flow

Investors look to the JPMorgan conference to kick off the year for life sciences, and last week's event in San Francisco did not disappoint. The nearly 5,500 "official" attendees made for packed halls and stuffed...
08:00 , Jan 12, 2004 |  BC Extra  |  Financial News

Inhibitex raises $20M

Infectious disease company Inhibitex raised $20 million in a series E round. Existing investors participated, and included New Enterprise Associates; William Blair Capital; Alliance Technology Ventures; Burrill Biotechnology Capital; Essex Woodlands Health Ventures; and Capital...